SI1728508T1 - Zdravilo za preprečevanje ali zdravljenje pogostega uriniranja ali urinske inkontinence - Google Patents

Zdravilo za preprečevanje ali zdravljenje pogostega uriniranja ali urinske inkontinence

Info

Publication number
SI1728508T1
SI1728508T1 SI200530851T SI200530851T SI1728508T1 SI 1728508 T1 SI1728508 T1 SI 1728508T1 SI 200530851 T SI200530851 T SI 200530851T SI 200530851 T SI200530851 T SI 200530851T SI 1728508 T1 SI1728508 T1 SI 1728508T1
Authority
SI
Slovenia
Prior art keywords
prevention
treatment
medicine
incontinence
urinary incontinence
Prior art date
Application number
SI200530851T
Other languages
English (en)
Inventor
Yoshinobu Yamazaki
Masami Kojima
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of SI1728508T1 publication Critical patent/SI1728508T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200530851T 2004-03-24 2005-03-17 Zdravilo za preprečevanje ali zdravljenje pogostega uriniranja ali urinske inkontinence SI1728508T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP2004/004000 WO2005092321A1 (ja) 2004-03-24 2004-03-24 頻尿または尿失禁の予防または治療用医薬組成物
PCT/JP2005/004825 WO2005089742A1 (ja) 2004-03-24 2005-03-17 頻尿または尿失禁の予防または治療用医薬
EP05721012A EP1728508B1 (en) 2004-03-24 2005-03-17 Medicine for prevention or treatment of frequent urination or urinary incontinence

Publications (1)

Publication Number Publication Date
SI1728508T1 true SI1728508T1 (sl) 2010-01-29

Family

ID=34993428

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530851T SI1728508T1 (sl) 2004-03-24 2005-03-17 Zdravilo za preprečevanje ali zdravljenje pogostega uriniranja ali urinske inkontinence

Country Status (12)

Country Link
US (1) US20080242674A1 (sl)
EP (1) EP1728508B1 (sl)
AT (1) ATE442137T1 (sl)
CA (1) CA2559646A1 (sl)
CY (1) CY1109546T1 (sl)
DE (1) DE602005016534D1 (sl)
DK (1) DK1728508T3 (sl)
ES (1) ES2331369T3 (sl)
PL (1) PL1728508T3 (sl)
PT (1) PT1728508E (sl)
SI (1) SI1728508T1 (sl)
WO (2) WO2005092321A1 (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
FR2895259B1 (fr) * 2005-12-22 2008-02-22 Urosphere Sas Methodes de traitement des incontinences urinaires
WO2008106125A2 (en) 2007-02-26 2008-09-04 Concert Pharmaceuticals, Inc. Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists
JP2010540621A (ja) * 2007-10-02 2010-12-24 ドン ア ファーマシューティカル カンパニー リミテッド 良性前立腺肥大症および下部尿路症状の治療または予防用組成物、およびその治療または予防方法
WO2010053068A1 (ja) * 2008-11-07 2010-05-14 大日本住友製薬株式会社 新規で有用な下部尿路症状治療剤
JP5426801B2 (ja) * 2011-08-25 2014-02-26 キッセイ薬品工業株式会社 低活動膀胱の予防または治療用医薬組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6426517A (en) * 1987-07-21 1989-01-27 Sankyo Co Remedy for dysuria
SE504276C2 (sv) * 1993-12-30 1996-12-23 Siko Medical Ab Ventil avsedd att placeras i urinröret
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6410554B1 (en) * 1998-03-23 2002-06-25 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
JP3154710B1 (ja) * 1999-08-09 2001-04-09 山之内製薬株式会社 下部尿路症治療剤
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
WO2002069906A2 (en) * 2001-03-06 2002-09-12 Cellegy Pharmaceuticals, Inc. Compounds and methods for the treatment of urogenital disorders
JP4132020B2 (ja) * 2001-03-12 2008-08-13 キッセイ薬品工業株式会社 フェノキシ酢酸誘導体の製造中間体およびその使用方法
JP2003055261A (ja) * 2001-08-08 2003-02-26 Pfizer Prod Inc 製剤組合せ
DK1426355T3 (da) * 2001-09-13 2009-02-23 Kissei Pharmaceutical Krystaller af hydroxynorephedrinderivater
AU2004285289A1 (en) * 2003-11-03 2005-05-12 Boehringer Ingelheim International Gmbh Pharmaceutical composition, containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha-reductase inhibitor
JP5004215B2 (ja) * 2004-03-05 2012-08-22 キッセイ薬品工業株式会社 神経障害に伴う過活動膀胱の予防または治療用医薬組成物

Also Published As

Publication number Publication date
PT1728508E (pt) 2009-10-20
EP1728508A4 (en) 2008-02-13
EP1728508A1 (en) 2006-12-06
US20080242674A1 (en) 2008-10-02
EP1728508B1 (en) 2009-09-09
WO2005089742A8 (ja) 2005-11-03
CY1109546T1 (el) 2014-08-13
WO2005092321A1 (ja) 2005-10-06
CA2559646A1 (en) 2005-09-29
ATE442137T1 (de) 2009-09-15
DE602005016534D1 (de) 2009-10-22
WO2005089742A1 (ja) 2005-09-29
ES2331369T3 (es) 2009-12-30
PL1728508T3 (pl) 2010-02-26
DK1728508T3 (da) 2010-01-25

Similar Documents

Publication Publication Date Title
CY1109546T1 (el) Φαρμακο για την προληψη η θεραπεια της συχνουριας η της ουρικης ακρατειας
HU229581B1 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
HK1062677A1 (en) 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
IL166748A0 (en) Pyrazole derivative medicinal composition containing the same medicinal use thereof and intermediatefor production thereof
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
MXPA03002779A (es) Derivados de glucopiranosiloxibencilbenceno y composiciones medicinales conteniendo los mismos.
FI943948A (fi) Heterosykliset hiilihappojohdannaiset
HK1094425A1 (en) Substituted 2-aminotetralines for the preventive treatment of parkinson's disease
UA95766C2 (ru) Производные терфенила для лечения болезни альцгеймера
PL1697394T3 (pl) Inhibitory COMT
WO2009084834A3 (en) Pharmaceutical composition for the treatment and prevention of cardiac disease
HK1101065A1 (sl)
BRPI0513549A (pt) composições farmacêuticas para o tratamento de leishmaniose
MA33619B1 (fr) Agent thérapeutique pour des troubles de l'anxiété
WO2006030322A3 (en) Use of fla vone/fla vanone derivatives fn the treatment or prevention of respiratory conditions
WO2008058995A3 (de) Verwendung von cytohesin-inhibitoren zur chemischen induktion von langlebigkeit
MY122400A (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same
EP2039354A4 (en) COMPOUND HAVING NMDA-RECEPTOR ACTIVE CHANNEL ACTIVATION ACTIVITY AND PHARMACEUTICAL AGENT USING THE SAME
WO2008102716A1 (ja) Ａｄｈｄ関連疾患治療剤
UA84544C2 (ru) Замещенные фенилсульфонамидные ингибиторы продукции бета-амилоида